Nisa Investment Advisors, LLC Amicus Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

$21.8 Billion
Q2 2025

A detailed history of Nisa Investment Advisors, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 2,948 shares of FOLD stock, worth $24,055. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,948

Previous 6,520 54.79%

Holding current value

$24,055

Previous $53,000 69.81%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Jul 31, 2025	SELL	$5.64 - $8.0 $20,146 - $28,576	-3,572 Reduced 54.79%	2,948 $16,000
Q1 2025 Apr 30, 2025	BUY	$8.16 - $9.85 $881 - $1,063	108 Added 1.68%	6,520 $53,000
Q4 2024 Jan 17, 2025	SELL	$9.36 - $12.01 $3,350 - $4,299	-358 Reduced 5.29%	6,412 $60,000
Q3 2024 Oct 24, 2024	SELL	$9.55 - $12.09 $12,902 - $16,333	-1,351 Reduced 16.64%	6,770 $72,000
Q2 2024 Jul 19, 2024	BUY	$9.04 - $11.75 $2,522 - $3,278	279 Added 3.56%	8,121 $80,000
Q1 2024 May 01, 2024	BUY	$11.43 - $14.24 $2,286 - $2,848	200 Added 2.62%	7,842 $92,000
Q4 2023 Jan 25, 2024	BUY	$9.97 - $14.52 $319 - $464	32 Added 0.42%	7,642 $108,000
Q2 2023 Aug 11, 2023	SELL	$10.72 - $13.3 $214 - $266	-20 Reduced 0.26%	7,610 $95,000
Q3 2022 Nov 07, 2022	BUY	$9.82 - $12.75 $1,865 - $2,422	190 Added 2.55%	7,630 $77,000
Q2 2022 Aug 03, 2022	SELL	$6.23 - $11.12 $7,102 - $12,676	-1,140 Reduced 13.29%	7,440 $80,000
Q1 2022 Apr 29, 2022	SELL	$7.89 - $12.48 $5,601 - $8,860	-710 Reduced 7.64%	8,580 $81,000
Q4 2021 Feb 03, 2022	SELL	$9.82 - $12.44 $14,140 - $17,913	-1,440 Reduced 13.42%	9,290 $87,000
Q2 2021 Aug 06, 2021	BUY	$8.71 - $10.72 $72,293 - $88,976	8,300 Added 341.56%	10,730 $103,000
Q1 2021 Apr 26, 2021	SELL	$9.2 - $23.86 $72,680 - $188,494	-7,900 Reduced 76.48%	2,430 $24,000
Q4 2020 Jan 25, 2021	BUY	$13.47 - $24.89 $18,858 - $34,846	1,400 Added 15.68%	10,330 $239,000
Q3 2020 Oct 20, 2020	BUY	$12.89 - $15.89 $88,941 - $109,641	6,900 Added 339.9%	8,930 $126,000
Q2 2020 Jul 27, 2020	BUY	$8.86 - $15.69 $1,860 - $3,294	210 Added 11.54%	2,030 $31,000
Q1 2020 Apr 17, 2020	SELL	$6.63 - $11.16 $9,613 - $16,182	-1,450 Reduced 44.34%	1,820 $17,000
Q4 2019 Jan 17, 2020	BUY	$7.48 - $10.75 $14,511 - $20,855	1,940 Added 145.86%	3,270 $32,000
Q3 2019 Oct 17, 2019	BUY	$8.02 - $13.25 $3,288 - $5,432	410 Added 44.57%	1,330 $11,000
Q3 2018 Oct 16, 2018	SELL	$11.6 - $16.54 $5,684 - $8,104	-490 Reduced 34.75%	920 $11,000
Q2 2018 Jul 19, 2018	BUY	$13.13 - $17.09 $2,757 - $3,588	210 Added 17.5%	1,410 $22,000
Q1 2018 Apr 10, 2018	SELL	$13.76 - $17.12 $6,329 - $7,875	-460 Reduced 27.71%	1,200 $18,000
Q3 2017 Oct 13, 2017	BUY	$11.74 - $15.78 $19,488 - $26,194	1,660	1,660 $25,000

Others Institutions Holding FOLD

# of Institutions

302

Shares Held

331M

Call Options Held

396K

Put Options Held

249K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.29B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Amicus Therapeutics, Inc. Transaction History